Thank you for taking this survey.

Boehringer Ingelheim is an expert in diabetes management, both for humans and animals. With a new, innovative feline diabetes product set to enter the US market this year, we wanted to know a little more about how pet diabetes has impacted our colleagues and their families. 

In appreciation for your time, you will be entered into a drawing for (X) when you submit your response. (Your answers will be kept anonymous.) 

* Required

Please select one of the following
1. What is your experience with diabetic pets?
2. If you had your choice, which of the following ways would you prefer to treat your diabetic cat?
3. If you had your choice, which of the following ways would you prefer to treat your diabetic dog?
4. Before you received your pet's diagnosis, how aware were you that pets could develop diabetes?
5. Which of the following best describes your pet’s diagnosis?
6. What is your least favorite part of treating your pet’s diabetes?
7. Do you, or have you, ever felt overwhelmed by the treatment requirements?
8. Given your experience treating pet diabetes, how beneficial do you think it will be for owners of newly diagnosed diabetic pets to be able to treat their pet with a once-daily oral liquid compared to twice-daily injections?